Cardinal Health Analysts Raise Their Forecasts Following Upbeat Earnings

Cardinal Health CAH reported better-than-expected second-quarter financial results on Thursday.

Cardinal Health posted adjusted earnings of $1.93 per share, beating market estimates of $1.76 per share. The company posted sales of $55.3 billion, topping expectations of $54.915 billion.

“We delivered strong second quarter financial results while taking significant strategic and operational actions to position us for future growth,” said Jason Hollar, CEO of Cardinal Health. “Led by robust demand across our Pharmaceutical and Specialty Solutions segment, we are again pleased to raise our fiscal 2025 enterprise guidance.”

Cardinal Health raised its FY25 non-GAAP earnings guidance from $7.75-$7.90 per share to $7.85-$8.00 per share.

Cardinal Health shares gained 1.3% to trade at $126.92 on Tuesday.

These analysts made changes to their price targets on Cardinal Health following earnings announcement.

Wells Fargo analyst Stephen Baxter maintained Cardinal Health with an Equal-Weight and raised the price target from $135 to $136.
JP Morgan analyst Lisa Gill maintained Cardinal Health with a Neutral and raised the price target from $142 to $145.

Considering buying CAH stock? Here’s what analysts think: